Results for lymphocytosis translation from English to Danish

lymphocytosis
lymphocytose

hunger lymphocytosis
hungerlymfocytose

thrombocytopenia, lymphopenia, lymphocytosis.
trombocytopeni, lymfopeni, lymfocytose.

febrile neutropenia leukocytosis lymphocytosis
febril neutropeni leukocytose lymfocytose

uncommon: thrombocytopenia, lymphopenia, lymphocytosis.
ikke almindelig: trombocytopeni, lymfopeni, lymfocytose.

anaemia1, thrombocytopenia3, thrombocythemia, eosinophilia1, leukocytosis2, lymphocytosis
anæmi1, trombocytopeni3, trombocytæmi, eosinofili1, leukocytose2, lymfocytose

lymphocytosis was not observed in patients with wm treated with imbruvica.
lymfocytose observeredes ikke hos patienter med wm, som blev behandlet med imbruvica.

neutropenia, leukopenia, thrombocytopenia, anaemia, lymphopenia, lymphadenopathy, lymphocytosis unknown:
neutropeni, leukopeni, thrombocytopeni, anæmi, lymfopeni, lymphadenopati, lymphocytose ukendt:

this observed lymphocytosis is a pharmacodynamic effect and should not be considered progressive disease in the absence of other clinical findings.
denne observerede lymfocytose er en farmakodynamisk effekt og bør ikke anses for progressiv sygdom i fravær af andre kliniske fund.

neutropenia, leukopenia, thrombocytopenia, anaemia, lymphopenia, lymphadenopathy, lymphocytosis immune system disorders common:
neutropeni, leukopeni, thrombocytopeni, anæmi, lymfopeni, lymphadenopati, lymphocytose immunsystemet almindelig:

in both disease types, lymphocytosis typically occurs during the first month of imbruvica therapy and typically resolves within a median of 8.0 weeks in patients with mcl and 14 weeks in patients with cll.
i begge sygdomstyper optræder lymfocytose typisk i løbet af den første behandlingsmåned med imbruvica og bedres typisk inden for en median på 8,0 uger hos patienter med mcl og 14 uger hos patienter med cll.

leucocytosis and lymphocytosis: in large placebo-controlled clinical studies, between 40 and 50% of patients developed sustained asymptomatic lymphocytosis during raptiva therapy.
leukocytose og lymfocytose: i store placebo-kontrollerede kliniske undersøgelser, udviklede mellem 40 og 50% af patienterne vedvarende asymptomatisk lymfocytose, mens de var i behandling med raptiva.

the most common side effects with raptiva (seen in more than 1 patient in 10) are mild to moderate flu-like symptoms including headache, fever, chills, nausea (feeling sick), myalgia (muscle pain), and leucocytosis and lymphocytosis (increased white blood cell counts).
de almindeligste bivirkninger af raptiva (som ses hos flere end 1 ud af 10 patienter) er lette til mode- rate influenzalignende symptomer som hovedpine, feber, kulderystelser, kvalme, muskelsmerter samt leukocytose og lymfocytose (forhøjet antal hvide blodlegemer).